Tag:

National Institutes of Health

COVID-19: 12 Symptoms Of Long COVID Revealed In New Study COVID-19: 12 Symptoms Of Long COVID Revealed In New Study
Covid-19: 12 Symptoms Of Long COVID Revealed In New Study A new study funded by the  National Institutes of Health is shedding light on one of the more complex aspects of the COVID-19 pandemic. So-called Long COVID is the term used for those who experience effects from their infection for months or more. The findings, released in the medical journal JAMA on Thursday, May 25, also identify 12 symptoms of Long COVID: Post-exertional malaise ( fatigue that worsens after physical or mental activity) Fatigue Dizziness Brain fog Loss of smell or taste Gastrointestinal symptoms Heart palpitations Thirst Chronic cough Chest pain Issues with se…
Good Hydration Linked To Lower Risk For Faster Aging, Disease, Early Death: New Study Good Hydration Linked To Lower Risk For Faster Aging, Disease, Early Death: New Study
Good Hydration Linked To Lower Risk For Faster Aging, Disease, Early Death: New Study Drinking enough water can help you lower the risk of disease, faster aging, and early death, according to a brand-new study. “The results suggest that proper hydration may slow down aging and prolong a disease-free life,” according to the study by the National Institutes of Health, which was published Monday, Jan. 2 in the journal eBioMedicine. Researchers who used data gathered from over 11,500 adults over a 30-year period analyzed links between serum sodium levels – which go up when fluid intake goes down – and various indicators of health.  They found that adults with serum sodium …
COVID-19: Five NY Residents Identified As Being Infected With Omicron Variant COVID-19: Five NY Residents Identified As Being Infected With Omicron Variant
Covid-19: Five NY Residents Identified As Being Infected With Omicron Variant Omicron, the new strain of COVID that has caused worldwide alarm the last week, has now been detected in five New York residents. Four are from New York City and the other was a 67-year-old Long Island woman who lives in Suffolk County and had recently traveled to South Africa, New York Gov. Kathy Hochul announced early Thursday evening, Dec. 2. All five had mild symptoms, Hochul said.  The vaccination status has only been determined for one of the five -- the Suffolk County woman who was fully vaccinated. She tested positive on Tuesday, Nov. 30, Hochul said. Two of the other fo…
COVID-19: First Cases Of New Variant Identified In North America COVID-19: First Cases Of New Variant Identified In North America
Covid-19: First Cases Of New Variant Identified In North America The new strain of COVID-19 that has caused worldwide alarm the last week has been detected in North America for the first time. Two cases of the Omicron variant were confirmed in Canada. Both were in Ottawa, Ontario Health Minister Christine Elliott said in a statement released Sunday evening, Nov. 28. The two infected people had traveled from Nigeria and have been isolated, Elliott said. The Omicron variant, whose name comes from the 15th letter of the Greek alphabet, is spreading fast in Europe after the first case was identified by scientists in South Africa on Tuesday, Nov. 9. In…
COVID-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says COVID-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says
Covid-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says Why are scientists so concerned about the new strain of COVID-19? Simply stated, when it comes to Omicron, it's all about the sheer numbers -- as in the number of mutations. "The main thing that has us focused on this and has caused us to be sort of 24-7 on Zoom calls the last four days is that it has so many mutations," Dr. Francis Collins, director of the National Institutes of Health (NIH), said Sunday morning, Nov. 28 on CNN. "Omicron has more than 50 variants that make it different from the original virus, including more than 30 that are in the spike protein." The spike proteins …
COVID-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says COVID-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says
Covid-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says Moderna has declared that its two-dose COVID-19 vaccine is safe and has produced a strong antibody response in children between the ages of 6 and 11. A new study of children in that age group found that the vaccine is safe to administer 28 days apart, according to the company and National Institutes of Health, which used shots with a 50 microgram dose of the vaccine, half the dosage for adults. In total, nearly 5,000 children participated in the study, the results of which were announced in a press release, but have yet to be peer-reviewed or published in a journal. The most common side …
REFLUX – OLOGY REFLUX – OLOGY
RefluxOlogy If you’re one of the estimated 17–27%* of adults who experience heartburn at least once a month, you know the signs: a harsh, burning feeling in your chest usually after eating a large meal, spicy food, or when you’re lying down. Frequent, persistent heartburn is the most common symptom of GERD (gastroesophageal reflux disease). GERD not only interferes with quality of life, it can lead to serious illness. If you have chronic GERD that is not relieved by lifestyle changes or medicines, surgery may be an option. But first, what causes GERD? When you eat, food travels from your mouth, down …
COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot
Covid-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot The timeline for COVID-19 booster shots may be accelerated as the US Food and Drug Administration (FDA) is expected to approve booster shots for all Americans after six months, not eight, as previously announced. According to reports, as more data is examined by federal health officials, it is more likely that booster shots will be required sooner than later for the Pfizer and Moderna vaccines. Before they can go into arms, the FDA must authorize booster shots for each vaccine. A spokesperson for the agency said that under its general policy it "cannot comment on or confirm the existence" o…
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…
COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots
Covid-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots Federal health officials have outlined their plans for when most Americans should get COVID-19 booster shots after becoming fully vaccinated. Pending authorization from the US Food and Drug Administration (FDA), a plan still being developed would advise Americans to get a COVID-19 booster shot eight months after becoming fully vaccinated to help stave off variants of the virus. Both Pfizer and Moderna, two of the three shots currently being administered in the US, have already submitted initial data to the FDA regarding their booster doses of their COVID-19 vaccines and are awaiting appro…
COVID-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills COVID-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills
Covid-19: US To Invest $3.2 Billion For Purchase Of Anti-Viral Pills President Joe Biden’s administration announced the United States is investing $3.2 billion to advance the development of antiviral drugs to treat viruses, including COVID-19. On Thursday, June 17, Biden announced the Antiviral Program for Pandemics, “a government-wide effort to speed up clinical trials of promising candidate drugs and develop next-generation treatments for Covid and other viruses that may cause future pandemics,” according to infectious disease expert Dr. Anthony Fauci. As part of the plan, the National Institutes of Health will “evaluate, prioritize, and advance” antivira…
COVID-19: Virus Was In Five States Before First Official Cases Reported, New Research Reveals COVID-19: Virus Was In Five States Before First Official Cases Reported, New Research Reveals
Covid-19: Virus Was In Five States Before First Official Cases Reported, New Research Reveals New research has found that the COVID-19 virus was circulating in at least five states for months before the first case was officially reported in the United States. According to a National Institutes of Health study published Tuesday, June 15 in the Clinical Infectious Diseases journal found that people in five states were infected with the virus in December 2019 and early in 2020 before the pandemic truly began last year. Researchers said that there was evidence of infection in nine out of 24,079 people whose blood samples were taken between Jan. 2, 2020, and March 18, 2020, suggesti…
COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says
Covid-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says New studies have found that Americans receiving the first dose of the two-shot Moderna and Pfizer COVID-19 vaccine may be protected against the spread of the vaccine. According to a Bloomberg report, out of more than 1,000 staff members tested at Cedars-Sinai Medical Center in Los Angeles, many responded to the first dose so robustly that their results were similar to co-workers who received both doses. Research leader Susan Cheng, who co-authored a study published in the Nature Medicine journal, said that those who have already contracted the virus, immune responses after one vaccine have …
COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses
Covid-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses Moderna is working on a booster shot for its two-dose COVID-19 vaccine that will be made available by the fall to help avoid another surge of new cases over the winter. CEO Stephane Bancel said on CNBC that the company “wants to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.” Last month, the National Institutes of Health began testing several versions of boosters from Moderna that could potentially be used to combat variants of COVID-19, including the South African strain that has flummoxed resear…
Why The COVID-19 Vaccine Is Important Why The COVID-19 Vaccine Is Important
Why The Covid-19 Vaccine Is Important As we all know, COVID-19 has caused very serious illness and even death for many people across our nation and around the world. Getting the COVID-19 vaccine is the best and safest choice to protect you, your family, and your community. Why should I get the COVID-19 vaccine? Is it safe? Since there is currently no cure for COVID-19, prevention is our best strategy. When you get the vaccine, your immune system gets a boost to help prevent you from getting COVID-19. The two COVID-19 vaccines being administered now, Pfizer and Moderna, have been approved for emergency use by the United States…
COVID-19 And The Heart: What We Now Know COVID-19 And The Heart: What We Now Know
Covid-19 And The Heart: What We Now Know During the COVID-19 pandemic, cardiovascular health remains a top health priority — with heart disease and stroke continuing to be the #1 and #5 leading causes of death in the U.S. There is a significant relationship between COVID-19 and cardiovascular disease, including more deaths from cardiovascular disease during the pandemic and serious heart conditions associated with an increased risk for severe illness from COVID-19. Nearly a quarter of the people hospitalized with COVID-19 develop myocardial injury or injury to the heart tissue and a significant number of patients have develope…
COVID-19: Have Questions About New Vaccine? Newly Launched Website Has Answers COVID-19: Have Questions About New Vaccine? Newly Launched Website Has Answers
Covid-19: Have Questions About New Vaccine? Newly Launched Website Has Answers With the first round of Pfizer’s COVID-19 vaccine set to be distributed potentially as soon as this weekend, a new interactive website has been launched that will answer any questions that one may have about the vaccination process. “COVID Vaccine Facts” has been set up by the Washington D.C.-based Biotechnology Innovation Organization (BIO) to help educate the public about the vaccine before it is shipped out by the federal government. “The content on this website serves as an educational tool to link people to third-party scientific and evidenced-based information related to the…
COVID-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals COVID-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals
Covid-19: High Percentage Of Those Infected With Virus Show No Symptoms, New Research Reveals An extraordinarily high percentage of COVID-19 infected people showed no symptoms of the disease, according to new research. Up to 40 percent of infected people "seem to have no symptoms," National Institutes of Health (NIH) Director Francis Collins said. "This might potentially explain why some people seem to fend off the virus and may be less susceptible to becoming severely ill," Collins wrote in a blog post.  Collins said it's "becoming apparent that our country is entering a new and troubling phase of the pandemic as SARS-CoV-2, the novel coronavirus that causes COVID-19, co…
COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says
Covid-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says A new report has examined why the novel coronavirus (COVID-19) spares some and has proven deadly for others. Months into the outbreak of the virus across the globe that broke out stateside in mid-March, scientists continue to investigate COVID-19 to determine how it chooses its victims. According to The Washington Post report, “the research remains provisional or ambiguous, and for now scientists can’t do much better than say that COVID-19 is more likely to be worse for older people — often described as over the age of 60 — and for those with chronic conditions such as …
Hudson River Health Care Responds To Coronavirus Outbreak in New York State Hudson River Health Care Responds To Coronavirus Outbreak in New York State
Hudson River Health Care Responds To Coronavirus Outbreak in New York State In response to the coronavirus (COVID-19) arriving in New York State, Hudson River Health Care (HRHCare) has equipped staff with information and resources at all 43 HRHCare health center locations across the Hudson Valley, New York City, and Long Island. The organization, which has provided health care to NYS communities for over 40 years, has also made public health experts available for interview either on the record or as a resource (bio/backgrounders below). HRHCare has created accessible information around the outbreak in multiple languages and reached out to patients via email and so…
Stony Brook University Professor Arrested For Using Cancer Research Funds For Personal Use Stony Brook University Professor Arrested For Using Cancer Research Funds For Personal Use
Stony Brook University Professor Arrested For Using Cancer Research Funds For Personal Use An associate professor at Stony Brook University has been arrested for allegedly stealing state and federal funding meant for cancer research for his own use, federal authorities say. Geoffrey Girnun, 48, of Woodmere, an associate professor in the Department of Pathology and director of Cancer Metabolomics at the Renaissance School of Medicine at the university was charged on Thursday, Sept. 12, in a seven-count indictment, said the United States Attorney for the Eastern District of New York. Girnun was charged with theft of state and federal government funds, wire fraud…
Hudson River Health Care Launches NIH All Of Us Research Program In Beacon Hudson River Health Care Launches NIH All Of Us Research Program In Beacon
Hudson River Health Care Launches NIH All Of Us Research Program In Beacon Hudson River Health Care (HRHCare) is pleased to announce that it launched the National Institutes of Health All of Us Research Program in Beacon on October 15, after successfully launching the program in Peekskill last year. This program is seeking one million or more participants nationwide to share their health information to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment and care for all of us. HRHCare Beacon has already enrolled 27 patients in the program, who join the 353 individuals that have enrolled in Peekskill since August 2017.…
Neurobiologist Picked As New Provost At Pace University Neurobiologist Picked As New Provost At Pace University
Neurobiologist Picked As New Provost At Pace University Pace University President Marvin Krislov has announced that Vanya Quiñones, Ph.D., a neurobiologist and biopsychologist who serves as Associate Provost for Student Success and Retention at CUNY’s Hunter College, will assume the role of Provost of Pace, effective July 1. Quiñones brings to Pace decades of experience in scientific research, academic administration, program- and research-focused fundraising, and a long record of working to improve diversity in science and the arts. As a young researcher at The Rockefeller University, Quiñones realized that she saw few who looked like her. Th…